1.71
1.71 (-1.37%)
As of Mar 06, 2024
Adaptimmune Therapeutics Plc [ADAP]
Source:
Company Overview
Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company focused on providing novel cell therapies to people with cancer. We are a leader in the development of T-cell therapies for solid tumors and have seen responses in six solid tumors in clinical trials.
Country | United States |
Headquarters | abingdon, oxfordshire |
Phone Number | 44 1235 430000 |
Industry | manufacturing |
CEO | Adrian Rawcliffe |
Website | www.adaptimmune.com |